Merck: A Race Against The Keytruda Clock

Group 1 - Merck is identified as a pharmaceutical company facing challenges due to a significant industry decline since 2024 [1] - The focus is on analyzing undervalued companies with strong fundamentals and cash flows, particularly in sectors like Oil & Gas and consumer goods [1] - Energy Transfer is highlighted as a previously overlooked investment opportunity that has shown resilience [1] Group 2 - The article emphasizes a long-term value investing approach while also exploring potential deal arbitrage opportunities [1] - There is a clear preference for businesses that are easily understandable, avoiding high-tech and certain consumer goods sectors [1] - The author expresses skepticism towards investments in cryptocurrencies [1]